Blinding
Blinding
Keeping some participants, investigators or assessors unaware of treatment allocation.
How to read it
Identify exactly who is blinded, rather than relying on single- or double-blind labels.
A common pitfall
Open-label trials can be informative, though some outcomes are more vulnerable to assessment bias.
Read it in context
Related readings will be added as the collection grows.